Bearish
TRAW Downgraded by HC Wainwright & Co. -- Price Target Adjusted to $1.00
HC Wainwright & Co. has downgraded Traws Pharma (TRAW) from Buy to Neutral, setting a new price target of $1.00, following a similar action by Ladenbu...
